Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis

被引:14
作者
Asahi, H [1 ]
Mizokami, A [1 ]
Maeda, Y [1 ]
Komatsu, K [1 ]
Koshida, K [1 ]
Namiki, M [1 ]
机构
[1] Yatsuo Gen Hosp, Toyama, Japan
关键词
prostatic neoplasms; neoplasm metastasis; bone neoplasms; diphosphonates; clodronic acid;
D O I
10.1016/S0022-5347(05)64093-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:281 / 282
页数:2
相关论文
共 3 条
[1]   The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer [J].
Heidenreich, A ;
Hofmann, R ;
Engelmann, UH .
JOURNAL OF UROLOGY, 2001, 165 (01) :136-140
[2]  
Lee MV, 2001, CANCER RES, V61, P2602
[3]   The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells [J].
Senaratne, SG ;
Mansi, JL ;
Colston, KW .
BRITISH JOURNAL OF CANCER, 2002, 86 (09) :1479-1486